Alignment Healthcare, Inc.
ALHC
$18.04
-$0.26-1.42%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 50.71% | 52.03% | 47.54% | 42.95% | 27.47% |
| Total Other Revenue | 48.26% | 22.60% | 30.72% | 62.22% | 272.76% |
| Total Revenue | 50.68% | 51.61% | 47.34% | 43.14% | 28.63% |
| Cost of Revenue | 47.19% | 54.18% | 47.41% | 44.64% | 28.15% |
| Gross Profit | 81.30% | 34.27% | 46.85% | 29.28% | 33.00% |
| SG&A Expenses | 17.67% | 11.43% | 24.59% | 28.10% | 2.95% |
| Depreciation & Amortization | 6.22% | 38.98% | 24.99% | 21.46% | 23.77% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 41.75% | 46.85% | 43.87% | 41.93% | 23.03% |
| Operating Income | 52.94% | 31.43% | 24.00% | -25.54% | 15.82% |
| Income Before Tax | 34.28% | 24.63% | 15.84% | -24.63% | 16.84% |
| Income Tax Expenses | 129.17% | -- | 2,100.00% | -- | -113.95% |
| Earnings from Continuing Operations | 34.23% | 24.65% | 15.76% | -24.63% | 17.13% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -222.73% | -46.67% | -141.18% | -37.93% | -76.09% |
| Net Income | 34.14% | 24.64% | 15.69% | -24.77% | 17.04% |
| EBIT | 52.94% | 31.43% | 24.00% | -25.54% | 15.82% |
| EBITDA | 63.60% | 48.84% | 37.80% | -26.36% | 19.75% |
| EPS Basic | 35.38% | 26.24% | 17.83% | -20.87% | 19.57% |
| Normalized Basic EPS | 47.73% | 23.19% | 20.08% | -19.75% | 15.00% |
| EPS Diluted | 35.38% | 26.24% | 17.83% | -20.87% | 19.57% |
| Normalized Diluted EPS | 47.73% | 23.19% | 20.08% | -19.75% | 15.00% |
| Average Basic Shares Outstanding | 1.89% | 2.15% | 2.63% | 3.22% | 3.17% |
| Average Diluted Shares Outstanding | 1.89% | 2.15% | 2.63% | 3.22% | 3.17% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |